For: | Xu CL, Guo Y, Qiao L, Ma L, Cheng YY. Recombinant expressed vasoactive intestinal peptide analogue ameliorates TNBS-induced colitis in rats. World J Gastroenterol 2018; 24(6): 706-715 [PMID: 29456409 DOI: 10.3748/wjg.v24.i6.706] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v24/i6/706.htm |
Number | Citing Articles |
1 |
Surbhi Aggarwal, Raju Ranjha, Jaishree Paul. Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases. World Journal of Gastrointestinal Pathophysiology 2021; 12(3): 25-39 doi: 10.4291/wjgp.v12.i3.25
|
2 |
Mete Özkoç, Betül Can, Hakan Şentürk, Dilek Burukoğlu Dönmez, Güngör Kanbak. Possible Curative Effects of Boric Acid and Bacillus clausii Treatments on TNBS-Induced Ulcerative Colitis in Rats. Biological Trace Element Research 2023; 201(3): 1237 doi: 10.1007/s12011-022-03215-5
|
3 |
Lei Wang, Xueqin Zhao, Xiaojing Xia, Chunling Zhu, Huihui Zhang, Wanhai Qin, Yanzhao Xu, Bolin Hang, Yawei Sun, Shijun Chen, Jinqing Jiang, Gaiping Zhang, Jianhe Hu. Inhibitory Effects of Antimicrobial Peptide JH-3 on Salmonella enterica Serovar Typhimurium Strain CVCC541 Infection-Induced Inflammatory Cytokine Release and Apoptosis in RAW264.7 Cells. Molecules 2019; 24(3): 596 doi: 10.3390/molecules24030596
|
4 |
Yong Zhou, Chen-Yu Zhang, Jia-Xi Duan, Qing Li, Hui-Hui Yang, Chen-Chen Sun, Jun Zhang, Xiao-Qin Luo, Shao-Kun Liu. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages. Biomedicine & Pharmacotherapy 2020; 121: 109596 doi: 10.1016/j.biopha.2019.109596
|
5 |
Yujiao Yang, Debo Yun, Biqian Dong, Yuan Geng, Yong Wan. VIP alleviates sepsis-induced cognitive dysfunction as the TLR-4/NF-κB signaling pathway is inhibited in the hippocampus of rats. Journal of Molecular Histology 2022; 53(2): 369 doi: 10.1007/s10735-022-10068-8
|
6 |
Lan Jin, Changhui Chen, Xinjun Jiang. Effects of Vasoactive Intestinal Polypeptide on Proliferation and Migration of Human Buccal Mucosa Fibroblasts. Journal of Hard Tissue Biology 2022; 31(2): 121 doi: 10.2485/jhtb.31.121
|
7 |
Andrzej Rychlik, Sławomir Gonkowski, Jarosław Całka, Krystyna Makowska. Vasoactive Intestinal Polypeptide (VIP) in the Intestinal Mucosal Nerve Fibers in Dogs with Inflammatory Bowel Disease. Animals 2020; 10(10): 1759 doi: 10.3390/ani10101759
|
8 |
Mari Iwasaki, Yasutada Akiba, Jonathan D Kaunitz. Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system. F1000Research 2019; 8: 1629 doi: 10.12688/f1000research.18039.1
|
9 |
Xiong Sun, Yao Huang, Ya-Li Zhang, Dan Qiao, Yan-Cheng Dai. Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells. World Journal of Gastroenterology 2020; 26(48): 7593-7602 doi: 10.3748/wjg.v26.i48.7593
|
10 |
Xue Song, Hexin Wen, Lugen Zuo, Zhijun Geng, Jing Nian, Luyao Wang, Yifan Jiang, Jing Tao, Zihan Zhu, Xiaopei Wu, Zhikun Wang, Xiaofeng Zhang, Liang Yu, Hao Zhao, Ping Xiang, Jing Li, Lin Shen, Jianguo Hu. Epac‐2 ameliorates spontaneous colitis in Il‐10−/− mice by protecting the intestinal barrier and suppressing NF‐κB/MAPK signalling. Journal of Cellular and Molecular Medicine 2022; 26(1): 216 doi: 10.1111/jcmm.17077
|
11 |
A. Bak, M. Ashford, D.J. Brayden. Local delivery of macromolecules to treat diseases associated with the colon. Advanced Drug Delivery Reviews 2018; : 2 doi: 10.1016/j.addr.2018.10.009
|
12 |
Haiyang Liu, Lulu Zhang, Jingmou Yu, Shengwen Shao. Advances in the application and mechanism of bioactive peptides in the treatment of inflammation. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1413179
|
13 |
Marianela González-González, Camilo Díaz-Zepeda, Johana Eyzaguirre-Velásquez, Camila González-Arancibia, Javier A. Bravo, Marcela Julio-Pieper. Investigating Gut Permeability in Animal Models of Disease. Frontiers in Physiology 2019; 9 doi: 10.3389/fphys.2018.01962
|
14 |
Ya’u Sabo Ajingi, Neeranuch Rukying, Aiyada Aroonsri, Nujarin Jongruja. Recombinant Active Peptides and their Therapeutic Functions. Current Pharmaceutical Biotechnology 2022; 23(5): 645 doi: 10.2174/1389201022666210702123934
|